EHTH eHealth (EHTH) Insider Trading, Ownership & Congress Trades
Insurance · Insurance agents, brokers & service · CIK 0001333493
Form 144 · 4
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
64
13F, latest reported quarter
What the filings say about EHTH
Insiders, 180 days
-$109.9K net sold
1 seller · 100% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$109.9K
4 notices
eHealth insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, eHealth, Inc. insiders sold a net $109.9K of stock across 30 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- 6 earlier Form 4 trades (code P or S) here by this insider (3 buys, 3 sales), the last on Oct 1, 2026.
- +23.3% median (+55.8% mean) 90-day return after 3 previous buys.
- The trade is 2.1% of the 974,609 shares held after it.
- No other insider sold within 30 days.
- 64 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director SOISTMAN FRANCIS S JR sold about $14.0K of EHTH under a 10b5-1 plan on Oct 2, 2026; 64 funds added in the latest 13F quarter.Context
- 5 earlier Form 4 trades (code P or S) here by this insider (3 buys, 2 sales), the last on Sep 1, 2026.
- +23.3% median (+55.8% mean) 90-day return after 3 previous buys.
- The trade is 2.0% of the 994,915 shares held after it.
- No other insider sold within 30 days.
- 64 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director SOISTMAN FRANCIS S JR sold about $14.1K of EHTH under a 10b5-1 plan on Oct 1, 2026; 64 funds added in the latest 13F quarter.Context
- 4 earlier Form 4 trades (code P or S) here by this insider (3 buys, 1 sale), the last on Aug 31, 2026.
- +23.3% median (+55.8% mean) 90-day return after 3 previous buys.
- The trade is 3.7% of the 1,015,221 shares held after it.
- No other insider sold within 30 days.
- 64 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director SOISTMAN FRANCIS S JR sold about $39.3K of EHTH under a 10b5-1 plan on Sep 1, 2026; 64 funds added in the latest 13F quarter.Context
- 3 earlier Form 4 trades (code P or S) here by this insider (3 buys), the last on Aug 8, 2024.
- +23.3% median (+55.8% mean) 90-day return after 3 previous buys.
- The trade is 3.5% of the 1,052,518 shares held after it.
- No other insider sold within 30 days.
- 64 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director SOISTMAN FRANCIS S JR sold about $42.4K of EHTH under a 10b5-1 plan on Aug 31, 2026, the largest insider sale at the company since 2024; 64 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 12.0% of the 208,755 shares held after it.
- 1 other insider bought within 30 days.
- 64 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Financial Officer Dolan John Joseph bought about $38.2K of EHTH on Mar 6, 2026; 1 other insider bought within 30 days and 64 funds added in the latest 13F quarter.30 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$109.9K over 180 days
-$109.9K over 90 days
more than 76% of Insurance
Congress
no House purchase disclosed in the last 12 months
Funds
64 funds bought in last quarter
below 78% of Insurance
Revenue
+4.1% year over year
below 68% of Insurance
Margin
7.2% net margin
below 61% of Insurance
Buybacks
no share repurchases reported
Short interest
2.1% of the float short (float per yahoo 2026-10-27) · 1.6 days to cover · settled 2026-10-15
below 76% of Insurance
What changed in the last 30 days
Oct 2Director SOISTMAN FRANCIS S JR sold $28.2K under a 10b5-1 plan (2 trades, Oct 1 to Oct 2)
Why it matters
A 10b5-1 plan schedules trades months ahead, so this says little about what the insider thinks today.
Oct 2Director FRANCIS S. SOISTMAN filed to sell $14.0K by Oct 2 (Form 144)
Why it matters
A Form 144 is a notice of intent to sell; the sale may not happen, and it says nothing about the price.
Oct 1Director FRANCIS S. SOISTMAN JR. filed to sell $14.1K by Oct 1 (Form 144)
Why it matters
A Form 144 is a notice of intent to sell; the sale may not happen, and it says nothing about the price.
Watch EHTH
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-89.6%12M
Insider buyInsider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns EHTH: institutional holders (13F)
13F holdings, latest reported quarter
3,522,882 sh
$5.2M
2,965,594 sh
$4.4M
2,288,414 sh
$3.4M
1,342,468 sh
$2.0M
1,180,462 sh
$1.8M
Congress trades in EHTH
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
EHTH planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
FRANCIS S. SOISTMAN
Filed 2026-10-02
$14.0K
FRANCIS S. SOISTMAN JR.
Filed 2026-10-01
$14.1K
FRANCIS S. SOISTMAN JR.
Filed 2026-09-01
$39.3K
FRANCIS S. SOISTMAN JR.
Filed 2026-08-31
$42.4K
EHTH mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Ultra-Small Company Market Fund
$55.1K position · as of 2026-06-30
0.0%
Venerable US Small Cap Fund
$41.8K position · as of 2026-06-30
0.0%
iShares Micro-Cap ETF
$148.1K position · as of 2026-06-30
0.0%
BlackRock Advantage SMID Cap V.I. Fund
$16.1K position · as of 2026-06-30
0.0%
Goldman Sachs ActiveBeta(R) U.S. Small Cap Equity ETF
$69.0K position · as of 2026-05-31
0.0%
1290 VT Micro Cap Portfolio
$9.8K position · as of 2026-06-30
0.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Corporate PAC
The company's PAC: committee totals only, never individual donors (FEC).
Ehealth Inc. Political Action Committee (Ehealth Pac)
Cycle 2026 · $46K spent
$47.2K
Federal Election Commission, matched by the PAC's connected organisation
Executive pay vs shareholder return · Francis S.Stoistman
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2024
$3.4M
$4.8M
$1.7M
-63%
n/a
2023
$5.0M
$6.7M
$1.9M
-66%
n/a
2022
$6.2M
-$190.9K
$1.3M
-81%
n/a
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $109.9K sold by insiders over 180 days, 64 funds added last quarter, $109.9K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
EHTH financials
Revenue growth
+4.1%
XBRL, annual
Net margin
7.2%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$501.7M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM EHTH
| FY Dec 2025 | $554.0M |
| FY Dec 2024 | $532.4M |
| FY Dec 2023 | $452.9M |
| FY Dec 2022 | $405.4M |
| FY Dec 2021 | $538.2M |
| Jun 2026 | $33.6M |
| Mar 2026 | $88.0M |
| Dec 2025 | $326.2M |
| Sep 2025 | $53.9M |
| Jun 2025 | $60.8M |
| Mar 2025 | $113.1M |
| Dec 2024 | $315.2M |
| Sep 2024 | $58.4M |
At each fiscal year end
Single quarter
Net margin, TTM
+5.4%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM EHTH
| FY Dec 2025 | +7.2% |
| FY Dec 2024 | +1.9% |
| FY Dec 2023 | -6.2% |
| FY Dec 2022 | -21.9% |
| FY Dec 2021 | -19.4% |
| Jun 2026 | -70.3% |
| Mar 2026 | -5.4% |
| Dec 2025 | +26.7% |
| Sep 2025 | -58.8% |
| Jun 2025 | -28.6% |
| Mar 2025 | +1.7% |
| Dec 2024 | +30.9% |
| Sep 2024 | -72.7% |
At each fiscal year end
Single quarter
Free cash flow, TTM
-$31.5M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM EHTH
| FY Dec 2025 | -$27.6M |
| FY Dec 2024 | -$20.5M |
| FY Dec 2023 | -$8.8M |
| FY Dec 2022 | -$27.1M |
| FY Dec 2021 | -$166.5M |
| Jun 2026 | -$5.4M |
| Mar 2026 | $35.6M |
| Dec 2025 | -$36.1M |
| Sep 2025 | -$25.5M |
| Jun 2025 | -$42.8M |
| Mar 2025 | $76.8M |
| Dec 2024 | -$28.3M |
| Sep 2024 | -$30.3M |
At each fiscal year end
Single quarter
Debt to equity
0.34x
long-term 2026-06-30 plus current 2025-06-30 (12 months older than the period end); equity 2026-06-30
Debt to equity EHTH
| FY Dec 2025 | 0.31x |
| FY Dec 2024 | 0.12x |
| FY Dec 2023 | 0.11x |
| FY Dec 2022 | 0.10x |
| FY Dec 2021 | 0.00x |
| Jun 2026 | 0.34x |
| Mar 2026 | 0.32x |
| Dec 2025 | 0.31x |
| Sep 2025 | 0.27x |
| Jun 2025 | 0.12x |
| Mar 2025 | 0.12x |
| Dec 2024 | 0.12x |
| Sep 2024 | 0.28x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
-0.17x
TTM operating cash flow over long-term 2026-06-30 plus current 2025-06-30 (12 months older than the period end)
Cash flow to debt EHTH
| FY Dec 2025 | -0.14x |
| FY Dec 2024 | -0.27x |
| FY Dec 2023 | -0.10x |
| FY Dec 2022 | -0.41x |
| FY Dec 2021 | n/a |
| Jun 2026 | -0.17x |
| Mar 2026 | -0.36x |
| Dec 2025 | -0.14x |
| Sep 2025 | -0.12x |
| Jun 2025 | -0.30x |
| Mar 2025 | -0.17x |
| Dec 2024 | -0.27x |
| Sep 2024 | -0.17x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+5.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity EHTH
| FY Dec 2025 | +6.8% |
| FY Dec 2024 | +1.7% |
| FY Dec 2023 | -4.5% |
| FY Dec 2022 | -12.7% |
| FY Dec 2021 | -13.2% |
| Jun 2026 | +5.0% |
| Mar 2026 | +5.8% |
| Dec 2025 | +6.8% |
| Sep 2025 | +9.9% |
| Jun 2025 | +7.2% |
| Mar 2025 | +5.0% |
| Dec 2024 | +1.7% |
| Sep 2024 | -6.7% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+2.4%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets EHTH
| FY Dec 2025 | +3.3% |
| FY Dec 2024 | +0.9% |
| FY Dec 2023 | -2.5% |
| FY Dec 2022 | -7.8% |
| FY Dec 2021 | -9.5% |
| Jun 2026 | +2.4% |
| Mar 2026 | +2.9% |
| Dec 2025 | +3.3% |
| Sep 2025 | +4.9% |
| Jun 2025 | +3.7% |
| Mar 2025 | +2.6% |
| Dec 2024 | +0.9% |
| Sep 2024 | -3.5% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+5.3%
operating income after a 35.7% effective tax rate, over long-term 2026-06-30 plus current 2025-06-30 (12 months older than the period end) plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital EHTH
| FY Dec 2025 | +6.3% |
| FY Dec 2024 | +2.1% |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | +5.3% |
| Mar 2026 | +6.0% |
| Dec 2025 | +6.3% |
| Sep 2025 | n/a |
| Jun 2025 | +8.4% |
| Mar 2025 | +6.4% |
| Dec 2024 | +2.1% |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+5.2%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed EHTH
| FY Dec 2025 | +6.0% |
| FY Dec 2024 | +2.3% |
| FY Dec 2023 | -2.8% |
| FY Dec 2022 | -9.7% |
| FY Dec 2021 | -12.4% |
| Jun 2026 | +5.2% |
| Mar 2026 | +5.5% |
| Dec 2025 | +6.0% |
| Sep 2025 | +5.4% |
| Jun 2025 | +5.4% |
| Mar 2025 | +4.8% |
| Dec 2024 | +2.3% |
| Sep 2024 | -3.1% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing EHTH
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | 25.35x |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$131.0M
market value at close 2026-10-26 on 2026-07-31 shares, plus long-term 2026-06-30 plus current 2025-06-30 (12 months older than the period end), minus cash 2026-06-30
Enterprise value EHTH
| FY Dec 2025 | $249.8M |
| FY Dec 2024 | $307.8M |
| FY Dec 2023 | $199.4M |
| FY Dec 2022 | $54.5M |
| FY Dec 2021 | $591.0M |
| Jun 2026 | $161.3M |
| Mar 2026 | $147.8M |
| Dec 2025 | $249.8M |
| Sep 2025 | $207.1M |
| Jun 2025 | $135.1M |
| Mar 2025 | $147.7M |
| Dec 2024 | $307.8M |
| Sep 2024 | $193.8M |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
-185.3%
TTM free cash flow over market value at close 2026-10-26
FCF yield EHTH
| FY Dec 2025 | -19.5% |
| FY Dec 2024 | -7.3% |
| FY Dec 2023 | -3.5% |
| FY Dec 2022 | -20.4% |
| FY Dec 2021 | -24.7% |
| Jun 2026 | -66.5% |
| Mar 2026 | -171.6% |
| Dec 2025 | -19.5% |
| Sep 2025 | -15.0% |
| Jun 2025 | -18.6% |
| Mar 2025 | -7.1% |
| Dec 2024 | -7.3% |
| Sep 2024 | -21.6% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing EHTH
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $554.0M | $532.4M | $452.9M | $405.4M |
| Gross profit | $240.8M | $208.5M | $159.2M | n/a |
| Operating income | $66.5M | $23.6M | -$29.1M | -$102.7M |
| Net income | $40.0M | $10.1M | -$28.2M | -$88.7M |
| EPS (diluted) | -0.34 | -1.19 | -2.37 | -4.36 |
| Operating cash flow | -$25.3M | -$18.4M | -$6.7M | -$26.9M |
| Cash | $73.7M | $39.2M | $115.7M | $144.4M |
| Long-term debt | $113.0M | $68.5M | $67.8M | $66.1M |
SEC XBRL, fiscal years, as known on 2026-10-28
EHTH Stock Sonar score 6/7 axes
Find similar shapesCompareEHTH ranks highest on risk and compliance (38th percentile) and institutional and government (36th), and lowest on insider conviction (1st), among Insurance peers.
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
EHTH filings, in plain words
Are eHealth insiders buying or selling EHTH?
In the 180 days to 2026-10-28, eHealth insiders were net sellers, a net $109.9K across purchases and sales reported on Form 4, by 1 seller.
Are there planned insider sales of EHTH?
Yes. 4 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $109.9K of stock; the latest, by FRANCIS S. SOISTMAN, was filed 2026-10-02.
Read the full summary
In the 180 days to 2026-10-28, eHealth insiders were net sellers of EHTH, a net $109.9K across purchases and sales reported on Form 4 by 1 seller. 100% of the 4 insider sales were made under a pre-arranged Rule 10b5-1 plan, so most selling was scheduled in advance. Insiders filed 4 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $109.9K of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
